Abstract:Background: The lifespan of Marfan Syndrome (MFS) patients is shortened, especially in patients without early diagnostics, preventive treatment, and elective surgery. Clinically, MFS diagnosis is mainly dependent on phenotypes, but for children, sporadic cases, or suspicious MFS patients, molecular genetic testing, and mainly FBN1 mutation screening, plays a significant role in the diagnosis of MFS. PGT-M gives couples that had a family history of monogenic disorders the opportunity to avoid the occurrence of MFS. Methods: In this study, 11 families with MFS were recruited and complete clinical features were collected. Variants were classified and interpreted through pedigree analysis according to guidelines. Two families chose to undergo PGT-M; 16 blastocysts were biopsied and amplified. Haplotype analysis was performed to deduce the embryo’s genotype by using single nucleotide polymorphisms (SNPs) identified in each sample. Results: We identified 11 potential disease-causing FBN1 variants, six of which are novel. All variants were assessed with prediction tools to assess mutation pathogenicity, population databases to evaluate population allele frequency, literature databases to identify whether the variant had been reported in MFS patients, and multiple sequence alignment to carry out conservative analysis. Finally, nine variants were classified as likely pathogenic/pathogenic variants. Among 11 variants, eight variants were missense, and seven of them were located in the Ca-binding EGF-like motifs, moreover, half of them substituted conserved Cysteine residues. We also identified a splice site variant, a frameshift variant, and a synonymous variant. There are two variants that are de novo variants. PGT-M helped two MFS families give birth to a healthy baby not carrying the FBN1 mutation. Conclusions: In the present study, the FBN1 mutation spectrum was enriched, and may help further elucidate the pathogenesis, benefiting clinical diagnosis and management of MFS. We make use of a reliable PGT-M method for the successful birth of healthy babies to two MFS families.

Identification Of A Novel Fbn1 Gene Mutation In A Chinese Family With Marfan Syndrome

Exon 47 Skipping of Fibrillin-1 Leads Preferentially to Cardiovascular Defects in Patients with Thoracic Aortic Aneurysms and Dissections

A Novel Mutation in Fibrillin-1 Gene Identified in a Chinese Family with Marfan Syndrome.

A Novel FBN1 Heterozygous Mutation Identified in a Chinese Family with Autosomal Dominant Marfan Syndrome.

A novel FBN1 mutation causes autosomal dominant Marfan syndrome.

A new novel mutation in FBN1 causes autosomal dominant Marfan syndrome in a Chinese family.

Novel Non-Synonymous Mutation in the Transforming Growth Factor Beta Binding Protein-Like (TB) Domain of the Fibrillin-1 (FBN1) Gene in a Han Chinese Family with Marfan Syndrome (MFS).

Mutation screening in the FBN1 gene responsible for Marfan syndrome and related disorder in Chinese families.

[Fibrillin-1 Gene Mutation in Chinese Patients with Marfan Syndrome and Its Gene Diagnosis by Haplotype Analysis].

[Mutation Analysis of FBN1 Gene in a Child with Marfan Syndrome].

A novel mutation in exon 18 of the FBN1 gene causes Marfan syndrome with cardiovascular and ocular abnormatities

[Analysis of FBN1 Genemutations in a Pedigree with Marfan Syndrome].

A FBN1 Mutation Association with Different Phenotypes of Marfan Syndrome in a Chinese Family.

Novel and Recurrent FBN1 Mutations Causing Marfan Syndrome in Two Chinese Families

[Analysis of FBN1 Gene Mutations in Two Pedigrees Affected with Marfan Syndrome].

Identification of a Novel FBN1 Mutation in a Chinese Family with Isolated Ectopia Lentis.

Two novel mutations of fibrillin-1 gene correlate with different phenotypes of Marfan syndrome in Chinese families.

Genetic analysis of a novel FBN1 mutation in a pediatric Marfan syndrome patient

Clinical feature of a family with Marfan syndrome and FBN-1 gene mutation site

A new novel mutation found in FBN1 gene of a patient with Marfan syndrome

Classification and Interpretation for 11 FBN1 Variants Responsible for Marfan Syndrome and Pre-implantation Genetic Testing (PGT) for Two Families Successfully Blocked Transmission of the Pathogenic Mutations